Teva Pharma Belgium
(Teva)
Laarstraat 16
2610 Antwerpen
BE
Public Limited Company
Juridical SituationNormal situation
Established2/3/1994
Medium
Wholesale trade excluding repair of motor vehicles and motorcycles
Management consultancy activities
Other manufacturing
ESG Risk Cases
11/7/2025Call to boycott Teva over its alleged support for the Israeli militaryMEDIUM ALERTUNRESOLVED
Accusation
In July 2025, the city of Genk and over 20 doctors launched a call to boycott Teva, citing the Israe…
Timeline
First report on 10/7/2025 by Het Belang van Limburg.
Since then, updated 3 times
Last update on 11/7/2025.
UNGC Violation Risks
Involved Companies
Teva Pharma Belgium
Sentiment Attention Over Time
No data available since 2024
Recent Relevant News
No data available since 2024
Often Mentioned With
Company Network
Financials
as of 31/12/2024
Key highlights
- Teva Pharma Belgium turnover grew to €75.2M (+€14.9M), with a net result of €1.6M (2% margin, 36% ROE).
- Financial position remains leveraged with total assets of €24.9M and a solvency ratio of 18%.
- Workforce efficiency is strong with 31.4 FTE generating an average turnover of €2.4M per employee.
Frequently Asked Questions
The VAT number for Teva Pharma Belgium is BE 0451951110.
Teva Pharma Belgium was established on 3 February 1994 and has been operating for 32 years.
The registered address for Teva Pharma Belgium is Laarstraat 16, 2610 Antwerpen, BE.
The latest annual accounts for Teva Pharma Belgium for the year 2024 were filed on 3/6/2025.
Based on the most recent annual accounts, Teva Pharma Belgium reports 31.4 FTEs.
In its latest annual accounts, Teva Pharma Belgium reported a turnover of €75.2M.
Teva Pharma Belgium is registered under the following NACE activities: Wholesale trade excluding repair of motor vehicles and motorcycles, Management consultancy activities, Other manufacturing.
Yes. We currently list 1 unresolved ESG risk cases for Teva Pharma Belgium.